Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Let's say

the BoD agrees and doesn't fight shareholders on their desire to nominate 1 person to the BoD. With five seats, that means one of the three amigos could lose a seat. That would break up the voting power of Falk, Felcyn and Johnson.

Would it seem likely that they would increase the number of seats back to six again to protect them from losing one of their own?

Share
New Message
Please login to post a reply